Laboratory of Cell and Molecular Biology, Institute for Biomedical Research (BIOMED), National Scientific and Technical Research Council (CONICET), Pontifical Catholic University of Argentina (UCA), Argentina.
Biochem Cell Biol. 2023 Dec 1;101(6):465-480. doi: 10.1139/bcb-2022-0352. Epub 2023 Jul 19.
GPRC5A is the first member of a new class of orphan receptors coupled to G proteins, which also includes GPRC5B, GPRC5C, and GPRC5D. Since its cloning and identification in the 1990s, substantial progress has been made in understanding the possible functions of this receptor. has been implicated in a variety of cellular events, such as cytoskeleton reorganization, cell proliferation, cell cycle regulation, migration, and survival. It appears to be a central player in different pathological processes, including tumorigenesis, inflammation, immune response, and tissue damage. The levels of expression differ depending on the type of cancer, with increased expression in colon, pancreas, and prostate cancers; decreased expression in lung cancer; and varied results in breast cancer. In this review, we discuss the early discovery of as a phorbol ester-induced gene and later as a retinoic acid-induced gene, its regulation, and its participation in important canonical pathways related to numerous types of tumors and inflammatory processes. represents a potential new target for cancer, inflammation, and immunity therapies.
GPRC5A 是与 G 蛋白偶联的一类新孤儿受体的第一个成员,该受体还包括 GPRC5B、GPRC5C 和 GPRC5D。自 20 世纪 90 年代克隆和鉴定以来,人们在理解该受体的可能功能方面取得了重大进展。已经涉及多种细胞事件,如细胞骨架重排、细胞增殖、细胞周期调节、迁移和存活。它似乎是包括肿瘤发生、炎症、免疫反应和组织损伤在内的不同病理过程中的核心参与者。表达水平因癌症类型而异,在结肠癌、胰腺癌和前列腺癌中表达增加;在肺癌中表达降低;在乳腺癌中则结果不一。在这篇综述中,我们讨论了 GPRC5A 作为佛波酯诱导基因和后来作为维甲酸诱导基因的早期发现、其调控以及其参与与多种类型肿瘤和炎症过程相关的重要经典途径。GPRC5A 代表了癌症、炎症和免疫治疗的一个潜在新靶点。